0001193125-15-184105.txt : 20150612 0001193125-15-184105.hdr.sgml : 20150612 20150512164735 ACCESSION NUMBER: 0001193125-15-184105 CONFORMED SUBMISSION TYPE: CORRESP PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20150512 FILER: COMPANY DATA: COMPANY CONFORMED NAME: MSB FINANCIAL CORP CENTRAL INDEX KEY: 0001635261 STANDARD INDUSTRIAL CLASSIFICATION: SAVINGS INSTITUTION, FEDERALLY CHARTERED [6035] IRS NUMBER: 000000000 STATE OF INCORPORATION: MD FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CORRESP BUSINESS ADDRESS: STREET 1: 1902 LONG HILL ROAD CITY: MILLINGTON STATE: NJ ZIP: 07946 BUSINESS PHONE: (908) 647-4000 MAIL ADDRESS: STREET 1: 1902 LONG HILL ROAD CITY: MILLINGTON STATE: NJ ZIP: 07946 CORRESP 1 filename1.htm Acceleration Request

[MSB FINANCIAL LETTERHEAD]

May 12, 2015

Via Edgar

Securities and Exchange Commission

100 F Street, N.E.

Washington, D.C. 20549

 

  Re: MSB Financial Corp.
    Registration Statement on Form S-1
    File No. 333-202573

Dear Sir or Madam:

Pursuant to Rule 461 of Regulation C, we hereby request acceleration of the above-referenced Registration Statement to May 14, 2015, at 2:00 p.m., Washington, D.C. time, or as soon thereafter on that day as is practicable that the staff of the Commission, acting pursuant to delegated authority, may determine.

We hereby acknowledge that:

 

    should the Commission or the staff, acting pursuant to delegated authority, declare the filing effective, it does not foreclose the Commission from taking any action with respect to the filing;
    the action of the Commission or the staff, acting pursuant to delegated authority, in declaring the filing effective, does not relieve the company from its full responsibility for the adequacy and accuracy of the disclosure in the filing; and
    the company may not assert the declaration of effectiveness as defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.

 

MSB FINANCIAL CORP.
By: /s/ Michael A. Shriner
Michael A. Shriner
President and Chief Executive Officer
(Duly Authorized Representative)